-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vartocell in Spinal Muscular Atrophy (SMA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vartocell in Spinal Muscular Atrophy (SMA) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Vartocell in Spinal Muscular Atrophy (SMA)Drug Details:Vartocell is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Camrelizumab in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Camrelizumab in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Camrelizumab in Cervical Cancer Drug Details: Camrelizumab (Airuika) is a humanized monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RG-6237 in Spinal Muscular Atrophy (SMA)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RG-6237 in Spinal Muscular Atrophy (SMA) Drug Details: RG-6237 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NMDP-02 in Spinal Muscular Atrophy (SMA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NMDP-02 in Spinal Muscular Atrophy (SMA) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NMDP-02 in Spinal Muscular Atrophy (SMA) Drug Details: NMDP-02 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BIIB-115 in Spinal Muscular Atrophy (SMA)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BIIB-115 in Spinal Muscular Atrophy (SMA) Drug Details: BIIB-115 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RG-6237 in Facioscapulohumeral Muscular Dystrophy (FSHD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RG-6237 in Facioscapulohumeral Muscular Dystrophy (FSHD) Drug Details: RG-6237 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Apitegromab in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apitegromab in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apitegromab in Obesity Drug Details: Apitegromab (SRK-015) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amifampridine Phosphate La in Lambert–Eaton Myasthenic Syndrome (LEMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amifampridine Phosphate La in Lambert–Eaton Myasthenic Syndrome (LEMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Amifampridine Phosphate La in Lambert–Eaton Myasthenic Syndrome (LEMS)Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SLATE-001 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SLATE-001 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SLATE-001 in Solid Tumor Drug Details: SLATE-001 is under development for the...
-
Sector Analysis
Solar PV Modules and Inverters Market Trends and Analysis by Technology, Installed Capacity, Generation, Key Players and Forecast to 2027
Reasons to buy the ‘Solar PV Modules and Inverters’ market sizing report: Analyze the solar PV module and inverter markets with a focus on market value and capacity at the global and regional levels including Asia-Pacific, Americas, Europe, and Middle East and Africa (EMEA). Identify key countries including the US, Chile, China, India, Japan, the UK, Germany, and France. Assess country-level solar market value and capacity for the historical and forecast periods. Get an insight into the competitive landscape at...